Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.

Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, Mullol J, Greos LS, Bosso JV, Laidlaw TM, Cervin AU, Maspero JF, Hopkins C, Olze H, Canonica GW, Paggiaro P, Cho SH, Fokkens WJ, Fujieda S, Zhang M, Lu X, Fan C, Draikiwicz S, Kamat SA, Khan A, Pirozzi G, Patel N, Graham NMH, Ruddy M, Staudinger H, Weinreich D, Stahl N, Yancopoulos GD, Mannent LP.

Lancet. 2019 Sep 19. pii: S0140-6736(19)31881-1. doi: 10.1016/S0140-6736(19)31881-1. [Epub ahead of print] Erratum in: Lancet. 2019 Sep 26;:.

PMID:
31543428
2.

Oral corticosteroids for painful acute otitis externa (swimmer's ear): A triple-blind randomised controlled trial.

Balch G, Heal C, Cervin A, Gunnarsson R.

Aust J Gen Pract. 2019 Aug;48(8):565-572.

3.

Inflammation and Endotyping in Chronic Rhinosinusitis-A Paradigm Shift.

Ahern S, Cervin A.

Medicina (Kaunas). 2019 Apr 5;55(4). pii: E95. doi: 10.3390/medicina55040095. Review.

4.

EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis.

Fokkens W, Desrosiers M, Harvey R, Hopkins C, Mullol J, Philpott C, Alobid I, Anselmo-Lima WT, Bachert C, Baroody F, Bernal-Sprekelsen M, von Buchwald C, Cervin A, Cohen N, Constantinidis J, De Gabory L, Douglas R, Gevaert P, Hafner A, Hellings P, Joos G, Kalogjera L, Kern R, Knill A, Kocks J, Landis BN, Limpens J, Lebeer S, Lourenco O, Matricardi PM, Meco C, O Mahony L, Reitsma S, Ryan D, Schlosser R, Senior B, Smith T, Teeling T, Tomazic PV, Toppila-Salmi S, Wang DY, Wang D, Zhang L, Lund V.

Rhinology. 2019 Jun 1;57(3):162-168. doi: 10.4193/Rhin17.253.

PMID:
30810118
5.

Phase 1 clinical study to assess the safety of a novel drug delivery system providing long-term topical steroid therapy for chronic rhinosinusitis.

Douglas RG, Psaltis AJ, Rimmer J, Kuruvilla T, Cervin A, Kuang Y.

Int Forum Allergy Rhinol. 2019 Apr;9(4):378-387. doi: 10.1002/alr.22288. Epub 2019 Jan 15.

PMID:
30645028
6.

Probiotics in the treatment of otitis media. The past, the present and the future.

Coleman A, Cervin A.

Int J Pediatr Otorhinolaryngol. 2019 Jan;116:135-140. doi: 10.1016/j.ijporl.2018.10.023. Epub 2018 Oct 19. Review.

PMID:
30554684
7.

The unsolved problem of otitis media in indigenous populations: a systematic review of upper respiratory and middle ear microbiology in indigenous children with otitis media.

Coleman A, Wood A, Bialasiewicz S, Ware RS, Marsh RL, Cervin A.

Microbiome. 2018 Nov 5;6(1):199. doi: 10.1186/s40168-018-0577-2.

8.

Ruptured popliteal artery aneurysm.

Cervin A, Ravn H, Björck M.

Br J Surg. 2018 Dec;105(13):1753-1758. doi: 10.1002/bjs.10953. Epub 2018 Jul 24.

9.

The Potential for Topical Probiotic Treatment of Chronic Rhinosinusitis, a Personal Perspective.

Cervin AU.

Front Cell Infect Microbiol. 2018 Jan 12;7:530. doi: 10.3389/fcimb.2017.00530. eCollection 2017. Review.

10.

Long-term patient-related outcome measures of septoplasty: a systematic review.

Tsang CLN, Nguyen T, Sivesind T, Cervin A.

Eur Arch Otorhinolaryngol. 2018 May;275(5):1039-1048. doi: 10.1007/s00405-018-4874-y. Epub 2018 Jan 13. Review.

PMID:
29332171
11.

CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis.

Hopkins C, Hettige R, Soni-Jaiswal A, Lakhani R, Carrie S, Cervin A, Douglas R, Fokkens WJ, Harvey R, Hellings PW, Leunig A, Lund VJ, Philpott C, Smith T, Wang DY, Rudmik L.

Rhinology. 2018 Mar 1;56(1):22-32. doi: 10.4193/Rhin17.247.

PMID:
29306959
12.

Clinical efficacy of a topical lactic acid bacterial microbiome in chronic rhinosinusitis: A randomized controlled trial.

Mårtensson A, Abolhalaj M, Lindstedt M, Mårtensson A, Olofsson TC, Vásquez A, Greiff L, Cervin A.

Laryngoscope Investig Otolaryngol. 2017 Nov 8;2(6):410-416. doi: 10.1002/lio2.93. eCollection 2017 Dec.

13.

Tonsillectomy or tonsillotomy? A systematic review for paediatric sleep-disordered breathing.

Zhang LY, Zhong L, David M, Cervin A.

Int J Pediatr Otorhinolaryngol. 2017 Dec;103:41-50. doi: 10.1016/j.ijporl.2017.10.008. Epub 2017 Oct 5. Review.

PMID:
29224763
14.

The effects of nasal lavage with betamethasone cream post-endoscopic sinus surgery: clinical trial.

Dawson B, Gutteridge I, Cervin A, Robinson D.

J Laryngol Otol. 2018 Feb;132(2):143-149. doi: 10.1017/S0022215117001827. Epub 2017 Sep 12.

PMID:
28893326
15.

Quality of Life and Work Capacity Are Unrelated to Approach or Complications After Pituitary Surgery.

Uvelius E, Castelo N, Kahlon B, Svensson C, Cervin A, Höglund P, Valdemarsson S, Siesjö P.

World Neurosurg. 2017 Dec;108:24-32. doi: 10.1016/j.wneu.2017.08.087. Epub 2017 Aug 30.

PMID:
28860094
16.

Rising incidence of head and neck mucosal melanoma in Australia.

Youssef D, Vasani S, Marquess J, Cervin A.

J Laryngol Otol. 2017 Jul;131(S2):S25-S28. doi: 10.1017/S0022215116009385. Epub 2016 Dec 5.

PMID:
27917723
17.

Melioidosis in a patient with chronic rhinosinusitis.

Phillips NM, Cervin A, Earnshaw J, Sidjabat HE.

J Laryngol Otol. 2016 Jul;130 Suppl 4:S60-2. doi: 10.1017/S0022215116008276. Review.

PMID:
27488340
18.

Effects of a honeybee lactic acid bacterial microbiome on human nasal symptoms, commensals, and biomarkers.

Mårtensson A, Greiff L, Lamei SS, Lindstedt M, Olofsson TC, Vasquez A, Cervin A.

Int Forum Allergy Rhinol. 2016 Sep;6(9):956-63. doi: 10.1002/alr.21762. Epub 2016 Apr 15.

PMID:
27080343
19.

Draft Genome Sequence of the Oral Commensal Streptococcus oralis 89a with Interference Activity against Respiratory Pathogens.

Sidjabat HE, Grahn Håkansson E, Cervin A.

Genome Announc. 2016 Jan 14;4(1). pii: e01546-15. doi: 10.1128/genomeA.01546-15.

20.

Healthcare provider contact for children with symptoms of sleep-disordered breathing: a population survey.

Gudnadottir G, Ehnhage A, Bende M, Andersson M, Cervin A, Cardell LO, Hellgren J.

J Laryngol Otol. 2016 Mar;130(3):296-301. doi: 10.1017/S0022215115003370. Epub 2015 Dec 17.

PMID:
26672803
21.

Draft Genome Sequences of Burkholderia pseudomallei and Staphylococcus aureus, Isolated from a Patient with Chronic Rhinosinusitis.

Sidjabat HE, Cottrell K, Cervin A.

Genome Announc. 2015 Oct 1;3(5). pii: e01075-15. doi: 10.1128/genomeA.01075-15.

22.

Biological effects and clinical efficacy of a topical Toll-like receptor 7 agonist in seasonal allergic rhinitis: a parallel group controlled phase IIa study.

Greiff L, Ahlström-Emanuelsson C, Alenäs M, Almqvist G, Andersson M, Cervin A, Dolata J, Lindgren S, Mårtensson A, Young B, Widegren H.

Inflamm Res. 2015 Nov;64(11):903-15. doi: 10.1007/s00011-015-0873-2. Epub 2015 Sep 5.

PMID:
26342289
23.

Cellular and molecular mechanisms of chronic rhinosinusitis and potential therapeutic strategies: review on cytokines, nuclear factor kappa B and transforming growth factor beta.

Phan NT, Cabot PJ, Wallwork BD, Cervin AU, Panizza BJ.

J Laryngol Otol. 2015 Jul;129 Suppl 3:S2-7. doi: 10.1017/S0022215115001322. Epub 2015 Jun 15. Review.

PMID:
26073199
24.

Treatment of Popliteal Aneurysm by Open and Endovascular Surgery: A Contemporary Study of 592 Procedures in Sweden.

Cervin A, Tjärnström J, Ravn H, Acosta S, Hultgren R, Welander M, Björck M.

Eur J Vasc Endovasc Surg. 2015 Sep;50(3):342-50. doi: 10.1016/j.ejvs.2015.03.026. Epub 2015 Apr 22.

25.

Reducing the number of rigid bronchoscopies performed in suspected foreign body aspiration cases via the use of chest computed tomography: is it safe? A literature review.

Tuckett P, Cervin A.

J Laryngol Otol. 2015 Jan;129 Suppl 1:S1-7. doi: 10.1017/S0022215114002862. Epub 2014 Nov 17. Review.

PMID:
25402832
26.

Treatment with a topical glucocorticoid, budesonide, reduced the variability of rhinomanometric nasal airway resistance.

Thulesius HL, Cervin A, Jessen M.

Rhinology. 2014 Mar;52(1):19-24. doi: 10.4193/Rhin12.180.

PMID:
24618623
27.

Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis.

Cervin A, Wallwork B.

Curr Allergy Asthma Rep. 2014 Mar;14(3):416. doi: 10.1007/s11882-013-0416-2. Review.

PMID:
24429901
28.

European Position Paper on Rhinosinusitis and Nasal Polyps 2012.

Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, Wang de Y, Wormald PJ.

Rhinol Suppl. 2012 Mar;23:3 p preceding table of contents, 1-298.

PMID:
22764607
29.

Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis.

Greiff L, Cervin A, Ahlström-Emanuelsson C, Almqvist G, Andersson M, Dolata J, Eriksson L, Högestätt E, Källén A, Norlén P, Sjölin IL, Widegren H.

Respir Res. 2012 Jun 22;13:53. doi: 10.1186/1465-9921-13-53.

30.

[International guidelines for allergic rhinitis have been updated].

Cardell LO, Wickman M, Hellgren J, Cervin A, Stjärne P, Holmström M, Dahlén B, Bjermer L, Dahlén SE.

Lakartidningen. 2012 Mar 21-27;109(12):622-4. Swedish. No abstract available.

PMID:
22624343
31.

EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.

Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, Wang de Y, Wormald PJ.

Rhinology. 2012 Mar;50(1):1-12. doi: 10.4193/Rhino50E2.

PMID:
22469599
32.

The importance of side difference in nasal obstruction and rhinomanometry: a retrospective correlation of symptoms and rhinomanometry in 1000 patients.

Thulesius HL, Cervin A, Jessen M.

Clin Otolaryngol. 2012 Feb;37(1):17-22. doi: 10.1111/j.1749-4486.2011.02420.x.

PMID:
22136145
33.

Is it time to abandon chronic rhinosinusitis? (Or at least to introduce the term unexplained chronic rhinosinusitis).

Cervin A.

Rhinology. 2010 Mar;48(1):123-4; discussion 124. No abstract available.

PMID:
21480569
34.

Can we always trust rhinomanometry?

Thulesius HL, Cervin A, Jessen M.

Rhinology. 2011 Mar;49(1):46-52. doi: 10.4193/Rhino10.027.

PMID:
21468374
35.

NOD-like receptors in the human upper airways: a potential role in nasal polyposis.

Månsson A, Bogefors J, Cervin A, Uddman R, Cardell LO.

Allergy. 2011 May;66(5):621-8. doi: 10.1111/j.1398-9995.2010.02527.x. Epub 2011 Jan 17.

PMID:
21241317
36.

Java simulations of embedded control systems.

Farias G, Cervin A, Arzén KE, Dormido S, Esquembre F.

Sensors (Basel). 2010;10(9):8585-603. doi: 10.3390/s100908585. Epub 2010 Sep 15.

37.

Allergic rhinitis and the common cold--high cost to society.

Hellgren J, Cervin A, Nordling S, Bergman A, Cardell LO.

Allergy. 2010 Jun 1;65(6):776-83. doi: 10.1111/j.1398-9995.2009.02269.x. Epub 2009 Nov 26.

PMID:
19958315
38.

Genes regulating molecular and cellular functions in noninfectious nonallergic rhinitis.

Cardell LO, Andersson M, Cervin A, Davidsson A, Hellgren J, Holmström M, Lundblad L, Stierna P, Stjärne P, Adner M; SRFA study group.

Allergy. 2009 Sep;64(9):1301-8. doi: 10.1111/j.1398-9995.2009.02009.x. Epub 2009 Apr 27.

PMID:
19432938
39.

Effects of long-term clarithromycin treatment on lavage-fluid markers of inflammation in chronic rhinosinusitis.

Cervin A, Wallwork B, Mackay-Sim A, Coman WB, Greiff L.

Clin Physiol Funct Imaging. 2009 Apr;29(2):136-42. doi: 10.1111/j.1475-097X.2008.00848.x. Epub 2008 Dec 8.

PMID:
19076731
40.

Macrolide therapy of chronic rhinosinusitis.

Cervin A, Wallwork B.

Rhinology. 2007 Dec;45(4):259-67. Review.

PMID:
18085018
41.

[Low dose CT better than regular radiography in diagnosis or rhinosinusitis. Should be the first choice].

Siemund R, Cervin A, Holje G, Svensson C, Forssell A.

Lakartidningen. 2007 Oct 10-16;104(41):2955-8. Swedish. No abstract available.

PMID:
17977304
42.

A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis.

Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A.

Laryngoscope. 2006 Feb;116(2):189-93.

PMID:
16467702
43.

Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis.

Cervin A, Wallwork B.

Otolaryngol Clin North Am. 2005 Dec;38(6):1339-50.

PMID:
16326189
44.

Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis.

Wallwork B, Coman W, Mackay-Sim A, Cervin A.

Laryngoscope. 2004 Feb;114(2):286-90.

PMID:
14755204
45.

Nasal septal perforations during treatment with topical nasal glucocorticosteroids are generally not associated with contact allergy to steroids.

Cervin A, Hansson C, Greiff L, Andersson M.

ORL J Otorhinolaryngol Relat Spec. 2003 Mar-Apr;65(2):103-5.

PMID:
12824732
46.

The paranasal sinuses as reservoirs for nitric oxide.

Andersson JA, Cervin A, Lindberg S, Uddman R, Cardell LO.

Acta Otolaryngol. 2002 Dec;122(8):861-5.

PMID:
12542206
47.

Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis.

Wallwork B, Coman W, Feron F, Mackay-Sim A, Cervin A.

Laryngoscope. 2002 Oct;112(10):1827-30.

PMID:
12368623
48.

A decrease in maxillary sinus pressure, as seen in upper airway allergy or infection, results in an increase in upper airway nitric oxide levels.

Andersson JA, Cervin A, Lindberg S, Uddman R, Cardell LO.

Acta Otolaryngol. 2002 Jul;122(5):520-3.

PMID:
12206262
49.
50.

Acute exudative inflammation and nasally exhaled nitric oxide are two independent phenomena.

Cervin A, Greiff L, Lindberg S, Andersson M.

ORL J Otorhinolaryngol Relat Spec. 2002 Jan-Feb;64(1):26-31.

PMID:
11891394

Supplemental Content

Loading ...
Support Center